Year archive

Valiant Laboratories Limited — 2026 filings

All 32 regulatory filings released by Valiant Laboratories Limited (VALIANTLAB) in 2026, sourced directly from the official regulator.

32 Filings

2026 Period

2026 filings (32)

Filing	Released	Lang
Annual Secretarial Compliance Report for the Financial Year 2025-2026. Regulatory Filings	2026-05-22	English
Disclosure under SEBI Takeover Regulations Major Shareholding Notification	2026-05-20	English
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, .... Major Shareholding Notification	2026-05-20	English
Updates Major Shareholding Notification	2026-05-19	English
Please find enclosed Major Shareholding Notification	2026-05-19	English
Valiant Laboratories Limited announces evaluation of Restructuring options. Regulatory Filings	2026-05-16	English
Press Release Regulatory Filings	2026-05-16	English
Copy of Newspaper Publication of Financial Results for the quarter and year ended 31 March, 2026. Earnings Release FY 2026	2026-05-16	English
Copy of Newspaper Publication Earnings Release FY 2026	2026-05-16	English
Monitoring Agency Report for quarter ended March 31, 2026 Regulatory Filings	2026-05-14	English
Monitoring Agency Report Regulatory Filings	2026-05-14	English
Audited Standalone and Consolidated Financial Results for quarter and year ended March 31, 2026. Audit Report / Information	2026-05-14	English
Outcome of Board Meeting Interim / Quarterly Report FY 2026	2026-05-14	English
Appointment of Cost Auditor and Internal Auditor. Regulatory Filings	2026-05-14	English
Outcome of Board Meeting Regulatory Filings	2026-05-14	English
Audited Standalone and Consolidated Financial Results for quarter and year ended March 31, 2026. Interim / Quarterly Report FY 2026	2026-05-14	English
Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. Interim / Quarterly Report FY 2026	2026-05-14	English
Outcome of Board Meeting Earnings Release FY 2026	2026-05-14	English
Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve financial results for .... Regulatory Filings	2026-05-11	English
Resignation of Director/KMP/SMP Regulatory Filings	2026-04-23	English
Resignation Board/Management Information	2026-04-23	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2026-04-13	English
Trading Window Regulatory Filings	2026-03-26	English
Copy of Newspaper Publication Regulatory Filings	2026-02-13	English
Monitoring Agency Report Regulatory Filings	2026-02-11	English
Outcome of Board Meeting Regulatory Filings	2026-02-11	English
Outcome of Board Meeting Regulatory Filings	2026-02-11	English
Board Meeting — Board Meeting Intimation Regulatory Filings	2026-02-06	English
Board Meeting — Financial Results Regulatory Filings	2026-02-06	English
Reply to Clarification- Financial results Regulatory Filings	2026-01-23	English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company Regulatory Filings	2026-01-15	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2026-01-07	English